Search alternatives:
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
m decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
12 m » 12 mm (Expand Search), 12 mg (Expand Search), 12 _ (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
m decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
12 m » 12 mm (Expand Search), 12 mg (Expand Search), 12 _ (Expand Search)
-
1841
-
1842
-
1843
-
1844
-
1845
-
1846
-
1847
Exposure to EtBr decreases mtRNA in rat striatal co-cultures, purified neuronal cultures, and astrocytes.
Published 2017“…<p>(A-C) Log2-fold decrease in mtRNA expression after EtBr treatment assayed with RNASeq, in (A) NECos, (B), pure neuronal cultures, and (C) astrocytes. …”
-
1848
-
1849
Cycloheximide (CHX) treatment decreases production of rRNA transcripts by POLR1 and POLR3.
Published 2019“…<p>(A) DAOY cells were treated with CHX (100 μg/ml) for either 6 or 14 hours; for metabolic RNA labelling, 5-EU was added 2 hours before the sample collection. …”
-
1850
-
1851
-
1852
-
1853
-
1854
S1 Data -
Published 2023“…The result is substantiated by significant decrease in blood glucose level in prevention (29.5 mg/dL; <i>p</i> = 0.002) and treatment (31.5 mg/dL; <i>p</i> = 0.006) groups, compared to stress group (47.33 mg/dL) at the end of the experiment. …”
-
1855
S2 Data -
Published 2023“…The result is substantiated by significant decrease in blood glucose level in prevention (29.5 mg/dL; <i>p</i> = 0.002) and treatment (31.5 mg/dL; <i>p</i> = 0.006) groups, compared to stress group (47.33 mg/dL) at the end of the experiment. …”
-
1856
-
1857
Image5_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg
Published 2024“…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
-
1858
-
1859
-
1860